Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Fink

Showing results (241-250 of 259) with videos related to

Pageof 26
Sort By:
The Journal of Infusional Chemotherapy|July 1, 1996
Weekly infusional 5-fluorouracil plus/minus other drugs for the treatment of advanced gastric cancerH Wilke, M Korn, U Vanhöfer, et al.
Blut|February 1, 1982
[Fibroblast interferon therapy in patients with NHL of low-grade malignancy: preliminary results (author's transl)]U Fink, W Siegert, D Huhn, et al.
Seminars in Oncology|April 1, 1992
Biochemical modulation of 5-fluorouracil by folinic acid or alpha-interferon with and without other cytostatic drugs in gastric, esophageal, and pancreatic cancerH Wilke, M Stahl, H J Schmoll, et al.
British Journal of Cancer|August 17, 2000
Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancerP M Schneider, H W Praeuer, O Stoeltzing, et al.
Anticancer Research|July 1, 1982
Treatment of non-hodgkin's lymphoma of low-grade malignancy with human fibroblast interferonW Siegert, H Theml, U Fink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
P53 mutational status improves estimation of prognosis in patients with curatively resected adenocarcinoma in Barrett's esophagusP M Schneider, O Stoeltzing, J A Roth, et al.
Investigational New Drugs|September 1, 1988
Phase I trial of the polyelectrolyte carbetimer administered i.v. once every four weeksM Fromm, W E Berdel, H D Schick, et al.
International Journal of Oncology|September 24, 1999
CD87-positive tumor cells in bone marrow aspirates identified by confocal laser scanning fluorescence microscopyF Noack, D Helmecke, R Rosenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Expression of p21WAF1 predicts outcome of esophageal cancer patients treated by surgery alone or by combined therapy modalitiesM Sarbia, M Stahl, A zur Hausen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001
Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imagingW A Weber, K Ott, K Becker, et al.
Pageof 26

Showing results (241-250 of 259) with videos related to

Sort By:
Pageof 26
The Journal of Infusional Chemotherapy|July 1, 1996
Weekly infusional 5-fluorouracil plus/minus other drugs for the treatment of advanced gastric cancerH Wilke, M Korn, U Vanhöfer, et al.
Blut|February 1, 1982
[Fibroblast interferon therapy in patients with NHL of low-grade malignancy: preliminary results (author's transl)]U Fink, W Siegert, D Huhn, et al.
Seminars in Oncology|April 1, 1992
Biochemical modulation of 5-fluorouracil by folinic acid or alpha-interferon with and without other cytostatic drugs in gastric, esophageal, and pancreatic cancerH Wilke, M Stahl, H J Schmoll, et al.
British Journal of Cancer|August 17, 2000
Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancerP M Schneider, H W Praeuer, O Stoeltzing, et al.
Anticancer Research|July 1, 1982
Treatment of non-hodgkin's lymphoma of low-grade malignancy with human fibroblast interferonW Siegert, H Theml, U Fink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
P53 mutational status improves estimation of prognosis in patients with curatively resected adenocarcinoma in Barrett's esophagusP M Schneider, O Stoeltzing, J A Roth, et al.
Investigational New Drugs|September 1, 1988
Phase I trial of the polyelectrolyte carbetimer administered i.v. once every four weeksM Fromm, W E Berdel, H D Schick, et al.
International Journal of Oncology|September 24, 1999
CD87-positive tumor cells in bone marrow aspirates identified by confocal laser scanning fluorescence microscopyF Noack, D Helmecke, R Rosenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Expression of p21WAF1 predicts outcome of esophageal cancer patients treated by surgery alone or by combined therapy modalitiesM Sarbia, M Stahl, A zur Hausen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001
Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imagingW A Weber, K Ott, K Becker, et al.
Pageof 26